Ancora Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
Sell
-20,574
Closed -$70K 1238
2016
Q3
$70K Buy
+20,574
New +$70K 0.01% 514